Bridging the Gap Between Human Research Participants, Investigators & Research Sponsors.
Board Members & Meetings
Opus IRB has been registered with the Office of Human Research Protection (OHRP) and
with the Food and Drug Administration (FDA). Opus IRB acts in accordance with all federal
regulations pertaining to the protection of human research participants.
Opus IRB is a central IRB with a diverse Board of Directors that can provide complete and
timely reviews of research protocols for private practice, hospital and universities. Opus
IRB can serve as the IRB of record for any institution that does not have its own local IRB
or the local IRB abdicates its authority to Opus IRB in writing.
Physicians participating on the Opus IRB board are disbursed throughout the United States. IRB meetings are scheduled once a week
with additional meetings scheduled as needed.
| Downloadable Copy |
 |
| Name | Position | Specialty Area |
| Henry Cremisi, MD | Chairman of the Board | Scientific, Nephrology |
| Lindsey Smith, RN | Board Member | Scientific, Pediatric |
| Chitra Edwin, Ph.D. | Board Member | Scientific ,Biopharmaceuticals |
| Caroline Lombard, JD | Board Member | Non-Scientific, Legal Subject Advocate |
| Katherine Smith, MMC | Board Member | Non-Scientific, Subject Advocate |
| Kimberly Schmitt, M.Div. | Board Member | Non-Scientific, Minister |
| Steven Caras, M.D., Ph.D | Board Member | Scientific, Clinical Development, Global Research |
| Robert Farnham, M.D. | Board Member | Scientific, Pathology |
Alternate Board Members
| Name | Position | Specialty Area |
| Richard Foulke, M.D. | Alternate Board Member | Scientific, Hematology-Oncology |